Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02376127 · ClinicalTrials.gov registry record
Metastatic Spinal Bone Marrow Response to Radiation Therapy Using T1 Weighted Dynamic Contrast-Enhanced Perfusion
A clinical trial of Solid Cancer and Metastatic Spinal Lesions, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 25
- Enrollment target
- 1
- Study location
NCT02376127 is a study of Solid Cancer and Metastatic Spinal Lesions that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 25 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02376127, a study of Solid Cancer and Metastatic Spinal Lesions, has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to assess imaging methods including Dynamic Contrast Enhanced Magnetic Resonance Imaging (DCE-MRI) and perfusion for the cancer that has spread to the spine. The study aims to see if using these methods will help better see response to treatment with radiation in patients with spine metastases from any solid cancer.
Conditions Studied
Interventions
- PROCEDURE Dynamic contrast enhancement MRI
Study Locations (1)
New York
- Memorial Sloan Kettering Cancer Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2015-02-24 |
| Est. Completion | 2025-07-16 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02376127
The ClinicalTrials.gov registry entry for NCT02376127 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Solid Cancer appearing as the primary indexed condition, and to 1 intervention - of which Dynamic contrast enhancement MRI is the first listed.
NCT02376127 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT02376127 about?
NCT02376127 is a clinical study titled "Metastatic Spinal Bone Marrow Response to Radiation Therapy Using T1 Weighted Dynamic Contrast-Enhanced Perfusion". The purpose of this study is to assess imaging methods including Dynamic Contrast Enhanced Magnetic Resonance Imaging (DCE-MRI) and perfusion for the cancer that has spread to the spine. The study aims to see if using these methods will help better see response to treatment with radiation in patient...
What is the current status of trial NCT02376127?
This trial is currently completed. The enrollment target is 25 participants. The study started on 2015-02-24. Estimated completion is 2025-07-16.
What conditions does trial NCT02376127 study?
This clinical trial studies the following conditions: Solid Cancer, Metastatic Spinal Lesions.
What interventions are being tested in trial NCT02376127?
The interventions under investigation include: Dynamic contrast enhancement MRI (PROCEDURE).
Who is sponsoring clinical trial NCT02376127?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02376127 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Solid Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.